Figure 1

Frequencies of pairs of ligands KIR-HLA Class I inhibitory and activating in leprosy patients and their clinical forms and healthy individuals in the population of Rondonopolis, MT. NOTE: Bars diagram depicting the frequency of pairs of KIR-HLA inhibitory and activacting. TT: Tuberculoid, Borderline (BL, BB, BT), LL: Lepromatous. ^*Represents that the LL group presented results of 0% for two activacting pairs. ^aTo one inhibitory pair: P = 0.006, OR = 1.8 (1.2 – 2.7) to per se vs. controls and P < 0.001, OR = 2.3 (1.5 – 3.6); to Borderline vs. controls. ^bTo two inhibitory pairs: P = 0.001, OR = 0.4 (0.2 – 0.8) to TT vs. controls. ^cTo one activating pair: P = 0.047, OR = 1.8 (1.0 – 3.1) to TT vs. controls. ^dTo two activating pairs: P = 0.024, OR = 11.0 (0.6 – 19.8) to TT vs. LL and P = 0.034, OR = 9.0 (0.5 – 15.1) to Borderline vs. LL.